Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery

Cationic niosomes have become important non-viral vehicles for transporting a good number of small drug molecules and macromolecules. Growing interest shown by these colloidal nanoparticles in therapy is determined by their structural similarities to liposomes. Cationic niosomes are usually obtained...

Descripción completa

Detalles Bibliográficos
Autores: Grijalvo, Santiago, Puras Ochoa, Gustavo, Zarate Sesma, Jon, Sainz Ramos, Myriam, Qtaish, Nuseibah A. L., López Méndez, Tania Belén, Mashal, Mohamed, Attia, Noha, Díaz Díaz, David, Pons, Ramón, Fernández, Eduardo, Pedraz Muñoz, José Luis
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universidad del País Vasco
Repositorio:Addi. Archivo Digital para la Docencia y la Investigación
OAI Identifier:oai:addi.ehu.eus:10810/32216
Acceso en línea:http://hdl.handle.net/10810/32216
Access Level:acceso abierto
Palabra clave:antisense oligonucleotides
aptamers
cationic lipids
cationic niosomes
gene delivery
plasmids
small interference RNA
therapy
nonionic surfactant vesicles
drug-delivery
lipid nanoparticles
helper lipids
breast-cancer
transfection efficiency
multidrug-resistance
therapeutic delivery
systemic delivery
Descripción
Sumario:Cationic niosomes have become important non-viral vehicles for transporting a good number of small drug molecules and macromolecules. Growing interest shown by these colloidal nanoparticles in therapy is determined by their structural similarities to liposomes. Cationic niosomes are usually obtained from the self-assembly of non-ionic surfactant molecules. This process can be governed not only by the nature of such surfactants but also by others factors like the presence of additives, formulation preparation and properties of the encapsulated hydrophobic or hydrophilic molecules. This review is aimed at providing recent information for using cationic niosomes for gene delivery purposes with particular emphasis on improving the transportation of antisense oligonucleotides (ASOs), small interference RNAs (siRNAs), aptamers and plasmids (pDNA).